RecruitingPhase not listedNCT06297291
Global Paradise System US Post Approval Study
Sponsor: ReCor Medical, Inc.
Gainesville, FL · Miami, FL · Pensacola, FL · +43 more sites
Hypertension clinical trials in Tampa, FL
10 recruiting hypertension studies with a site in Tampa, FL.
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Boca Raton, FL · Brandon, FL · Fleming Island, FL · +270 more sites
RecruitingPhase 3NCT07179380
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Sponsor: Insmed Incorporated
Gainesville, FL · Naples, FL · St. Petersburg, FL · +16 more sites
RecruitingPhase 2NCT07142356
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Sponsor: Retension Pharmaceuticals. Inc.
Maitland, FL · Orlando, FL · Port Orange, FL · +31 more sites
RecruitingNot applicableNCT06559891
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Sponsor: SoniVie Inc.
Pensacola, FL · Safety Harbor, FL · Tampa, FL · +31 more sites
RecruitingPhase 1 / Phase 2NCT07143448
A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
Sponsor: 35Pharma Inc
Tampa, FL · +1 more sites
RecruitingPhase not listedNCT06388421
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Sponsor: United Therapeutics
Gainesville, FL · Naples, FL · Orlando, FL · +67 more sites
RecruitingPhase 2NCT07543120
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Sponsor: Novartis Pharmaceuticals
Brandon, FL · Miami, FL · Miami Lakes, FL · +16 more sites
RecruitingPhase 1 / Phase 2NCT06649110
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Sponsor: Novartis Pharmaceuticals
Orlando, FL · Tampa, FL · +18 more sites
RecruitingPhase not listedNCT06129240
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Sponsor: Liquidia Technologies, Inc.
Orlando, FL · Tampa, FL · +21 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.